Abstract |
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the 21-hydroxylase gene (CYP21A2), coding for the enzyme 21-hydroxylase (21-OH). About 95% of the mutations arise from gene conversion between CYP21A2 and the inactive pseudogene CYP21A1P: only 5% are novel CYP21A2 mutations, in which functional analysis of mutant enzymes has been helpful to correlate genotype-phenotype. In the present study, we describe 3 novel point mutations (p.L122P, p.Q481X, and p.E161X) in 3 Italian patients with CAH: the fourth mutation (p.M150R) was found in the carrier state. Molecular modeling suggests a major impact on 21-hydroxylase activity, and functional analysis after expression in COS-7 cells confirms reduced enzymatic activity of the mutant enzymes. Only the p.M150R mutation affected the activity to a minor extent, associated with NC CAH. CYP21A2 genotyping and functional characterization of each disease-causing mutation has relevance both for treatment and genetic counseling to the patients.
|
Authors | A Massimi, M Malaponti, L Federici, D Vinciguerra, M L Manca Bitti, A Vottero, L Ghizzoni, M Maccarrone, M Cappa, S Bernardini, O Porzio |
Journal | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
(Horm Metab Res)
Vol. 46
Issue 7
Pg. 515-20
(Jun 2014)
ISSN: 1439-4286 [Electronic] Germany |
PMID | 24799024
(Publication Type: Case Reports, Journal Article)
|
Copyright | © Georg Thieme Verlag KG Stuttgart · New York. |
Chemical References |
- Mutant Proteins
- Steroid 21-Hydroxylase
|
Topics |
- Adrenal Hyperplasia, Congenital
(enzymology, genetics)
- Amino Acid Sequence
- Animals
- Blotting, Western
- COS Cells
- Child
- Chlorocebus aethiops
- Female
- Genotype
- Humans
- Infant, Newborn
- Italy
- Male
- Molecular Sequence Data
- Mutant Proteins
(metabolism)
- Mutation
(genetics)
- Phenotype
- Protein Structure, Secondary
- Sequence Alignment
- Steroid 21-Hydroxylase
(chemistry, genetics)
|